author-photo

Peter te Boekhorst

Erasmus University Rotterdam

65

Papers

1190

Citations

Citation Trend

Filter By

Papers (49) Sort By

Journal Conference Others

Effects of Potent Neutralizing Antibodies from Convalescent Plasma in Patients Hospitalized for Severe SARS-CoV-2 Infection.

2020
Show All
- Source
- Cite
- Save
Citations (38)
An International Multicentric Observational Study on the Use of Ruxolitinib in Patients with Polycythemia Vera Resistant or Intolerant to Hydroxyurea: Results from Interim Analysis

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Results of the prematurely terminated TEMPLE randomized controlled trial in patients with myelodysplastic syndrome: liberal versus restrictive red blood cell transfusion threshold

2020 Transfusion
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 3919: Liquid biopsy derived organoids as a potential platform for personalized cancer therapy in metastatic prostate cancer

2020 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (1)
New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia

2019 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (18)
EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (13)
The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study

2019 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (4)
Patchy hematopoiesis mimicking bone metastasis

2018 Blood
- A. C. Cornelisse
- Peter te Boekhorst
Show All
- Source
- Cite
- Save
Citations (2)
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial

2018 Blood
Show All
- Source
- Cite
- Save
Citations (40)
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

2017 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (113)